HAT1 and osteosarcoma: In Xia and colleagues' research, the analysis results showed upregulated HAT1 in osteosarcoma (OS), while miR-377 could promote the OS cell apoptosis and even mitigate tumor growth through inhibition of the Wnt signaling pathway via suppressing HAT1 [6].